D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$402M |
| 2 |
AGN
Allergan plc
AGN
|
+$371M |
| 3 |
Bank of America
BAC
|
+$323M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$236M |
Top Sells
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$364M |
| 4 |
Phillips 66
PSX
|
+$352M |
| 5 |
Apple
AAPL
|
+$350M |
Sector Composition
| 1 | Healthcare | 15.91% |
| 2 | Technology | 12.6% |
| 3 | Financials | 12.08% |
| 4 | Consumer Discretionary | 10.42% |
| 5 | Communication Services | 10.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Phibro Animal Health
PAHC
$1.67B
| $238K | ﹤0.01% |
8,796
-4,884
| -36% | -$132K |
|
|
RAVN
2302
DELISTED
Raven Industries Inc
RAVN
| $237K | ﹤0.01% |
+14,808
| New | +$237K |
|
2303
CarMax
KMX
$8.88B
| $235K | ﹤0.01% |
+4,600
| New | +$235K |
|
2304
Lumen
LUMN
$6.3B
| $235K | ﹤0.01% |
7,347
-59,834
| -89% | -$1.91M |
|
2305
American Water Works
AWK
$27B
| $234K | ﹤0.01% |
3,400
-2,349
| -41% | -$162K |
|
|
MFLX
2306
DELISTED
MULTI-FINELINE ELECTRONIX INC
MFLX
| $234K | ﹤0.01% |
10,092
-5,414
| -35% | -$126K |
|
|
PFSW
2307
DELISTED
PFSweb, Inc.
PFSW
| $234K | ﹤0.01% |
17,807
+1,800
| +11% | +$23.7K |
|
2308
CubeSmart
CUBE
$9.29B
| $233K | ﹤0.01% |
+6,984
| New | +$233K |
|
2309
LG Display
LPL
$4.33B
| $233K | ﹤0.01% |
20,391
-5,465
| -21% | -$62.4K |
|
|
EXK
2310
Endeavour Silver
EXK
$1.71B
| $232K | ﹤0.01% |
94,123
+46,530
| +98% | +$115K |
|
2311
Heritage Insurance Holdings
HRTG
$683M
| $232K | ﹤0.01% |
14,513
-1,354
| -9% | -$21.6K |
|
|
RPRX
2312
DELISTED
Repros Therapeutics Inc.
RPRX
| $232K | ﹤0.01% |
239,548
-30,561
| -11% | -$29.6K |
|
2313
Avient
AVNT
$3.34B
| $231K | ﹤0.01% |
+7,630
| New | +$231K |
|
2314
Northrop Grumman
NOC
$83B
| $231K | ﹤0.01% |
1,168
-11,606
| -91% | -$2.3M |
|
2315
Opko Health
OPK
$1.12B
| $231K | ﹤0.01% |
22,200
-555,153
| -96% | -$5.78M |
|
|
STML
2316
DELISTED
Stemline Therapeutics, Inc.
STML
| $231K | ﹤0.01% |
49,597
-3,432
| -6% | -$16K |
|
2317
Alamos Gold
AGI
$13.9B
| $230K | ﹤0.01% |
43,407
+9,022
| +26% | +$47.8K |
|
|
BIOL
2318
DELISTED
Biolase, Inc.
BIOL
| $230K | ﹤0.01% |
14
| – | – |
|
|
CAS
2319
DELISTED
A M Castle & Co
CAS
| $230K | ﹤0.01% |
85,340
-20,426
| -19% | -$55.1K |
|
2320
FirstCash
FCFS
$6.46B
| $229K | ﹤0.01% |
4,970
-2,032
| -29% | -$93.6K |
|
2321
Q2 Holdings
QTWO
$5.13B
| $229K | ﹤0.01% |
9,535
-56,245
| -86% | -$1.35M |
|
|
TTOO
2322
DELISTED
T2 Biosystems, Inc
TTOO
| $228K | ﹤0.01% |
5
+2
| +67% | +$91.2K |
|
|
UAM
2323
DELISTED
Universal American Corp
UAM
| $227K | ﹤0.01% |
31,757
+5,907
| +23% | +$42.2K |
|
2324
Mid-America Apartment Communities
MAA
$16.6B
| $226K | ﹤0.01% |
2,209
| – | – |
|
|
NVTA
2325
DELISTED
Invitae Corporation
NVTA
| $226K | ﹤0.01% |
+22,136
| New | +$226K |
|